Christopher Lewis Stone - Net Worth and Insider Trading

Christopher Lewis Stone Net Worth

The estimated net worth of Christopher Lewis Stone is at least $1 Million dollars as of 2024-05-05. Christopher Lewis Stone is the VP, Gen. Counsel & Secretary of PDL BioPharma Inc and owns about 405,559 shares of PDL BioPharma Inc (PDLI) stock worth over $1 Million. Details can be seen in Christopher Lewis Stone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Lewis Stone has not made any transactions after 2020-12-16 and currently still holds the listed stock(s).

Transaction Summary of Christopher Lewis Stone

To

Christopher Lewis Stone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Lewis Stone owns 1 companies in total, including PDL BioPharma Inc (PDLI) .

Click here to see the complete history of Christopher Lewis Stone’s form 4 insider trades.

Insider Ownership Summary of Christopher Lewis Stone

Ticker Comapny Transaction Date Type of Owner
PDLI PDL BioPharma Inc 2020-12-16 VP & Gen. Counsel & Secretary

Christopher Lewis Stone Latest Holdings Summary

Christopher Lewis Stone currently owns a total of 1 stock. Christopher Lewis Stone owns 405,559 shares of PDL BioPharma Inc (PDLI) as of December 16, 2020, with a value of $1 Million.

Latest Holdings of Christopher Lewis Stone

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDLI PDL BioPharma Inc 2020-12-16 405,559 2.47 1,001,731

Holding Weightings of Christopher Lewis Stone


Christopher Lewis Stone Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Lewis Stone has made a total of 1 transactions in PDL BioPharma Inc (PDLI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in PDL BioPharma Inc is the sale of 200,000 shares on December 16, 2020, which brought Christopher Lewis Stone around $512,000.

Insider Trading History of Christopher Lewis Stone

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Lewis Stone Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Lewis Stone Ownership Network

Ownership Network List of Christopher Lewis Stone

No Data

Ownership Network Relation of Christopher Lewis Stone


Christopher Lewis Stone Owned Company Details

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

Christopher Lewis Stone is the VP & Gen. Counsel & Secretary of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP Finance & CAO and Acting CFO Edward Imbrogno , and VP & Business Development Jill M. Jene .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PDL BioPharma Inc Insider Transactions

No Available Data

Christopher Lewis Stone Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Lewis Stone. You might contact Christopher Lewis Stone via mailing address: 932 Southwood Blvd. Incline Village Nv 89451.

Discussions on Christopher Lewis Stone

No discussions yet.